世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

神経系バイオマーカーの世界市場 2022-2026


Global Neurological Biomarkers Market 2022-2026

神経学的バイオマーカーの世界市場2022-2026年 Technavioは神経学的バイオマーカー市場を監視しており、2022-2026年の間に60億ドルの成長が見込まれ、予測期間中に12.43%のCAGRで加速しています。当レポートでは... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年6月27日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報・注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

神経学的バイオマーカーの世界市場2022-2026年
Technavioは神経学的バイオマーカー市場を監視しており、2022-2026年の間に60億ドルの成長が見込まれ、予測期間中に12.43%のCAGRで加速しています。当レポートでは、神経学的バイオマーカー市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。神経疾患の発生率の増加、各国での臨床試験の増加、政府や医療機関による取り組みや支援の増加などが市場を牽引しています。
神経学的バイオマーカー市場の分析には、エンドユーザーセグメントと地理的展望が含まれます。
Technavioの神経学的バイオマーカー市場は、以下のように区分されています。
エンドユーザー別
- 病院
- 臨床診断センター
- 研究機関、その他
地理的状況別
- 北米
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、正確な神経学的診断への注目が高まっていることが、今後数年間の神経学的バイオマーカー市場の成長を促進する主要な理由の1つであると特定しています。また、神経疾患のための血液ベースのバイオマーカーとmiRNAの進化は、市場での大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。神経学的バイオマーカー市場に関する当レポートの対象領域は以下の通りです。
- 神経学的バイオマーカー市場のサイジング
- 神経学的バイオマーカー市場の予測
- 神経学的バイオマーカー市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Bio Rad Laboratories Inc.、Proteome Sciences plc、QIAGEN NV、Thermo Fisher Scientific Inc.など、いくつかの主要神経バイオマーカー市場ベンダーについて詳細に分析しています。Merck KGaA、F. Hoffmann La Roche Ltd.、Myriad Genetics Inc.、bioMerieux SA、Charles River Laboratories International Inc、Quest Diagnostics Inc、PerkinElmer Inc、Metabolon Inc、Acrobiosystems Inc、HU Group Holdings Inc、Enzo Biochem Inc、Eli Lilly and Co、Abbott Laboratories、Advanced Brain Monitoring Inc、Johnson and Johnson、Quanterix Corp.等、複数の主要ベンダーについて詳細に分析しています。また、神経学的バイオマーカー市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/neurological-biomarkers-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 18: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 21: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 22: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 23: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 24: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Indication
o 5.1 Market segments
o Exhibit 25: Chart on Indication - Market share 2021-2026 (%)
o Exhibit 26: Data Table on Indication - Market share 2021-2026 (%)
o 5.2 Comparison by Indication
o Exhibit 27: Chart on Comparison by Indication
o Exhibit 28: Data Table on Comparison by Indication
o 5.3 AD - Market size and forecast 2021-2026
o Exhibit 29: Chart on AD - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Data Table on AD - Market size and forecast 2021-2026 ($ million)
o Exhibit 31: Chart on AD - Year-over-year growth 2021-2026 (%)
o Exhibit 32: Data Table on AD - Year-over-year growth 2021-2026 (%)
o 5.4 PD - Market size and forecast 2021-2026
o Exhibit 33: Chart on PD - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Data Table on PD - Market size and forecast 2021-2026 ($ million)
o Exhibit 35: Chart on PD - Year-over-year growth 2021-2026 (%)
o Exhibit 36: Data Table on PD - Year-over-year growth 2021-2026 (%)
o 5.5 ASD - Market size and forecast 2021-2026
o Exhibit 37: Chart on ASD - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Data Table on ASD - Market size and forecast 2021-2026 ($ million)
o Exhibit 39: Chart on ASD - Year-over-year growth 2021-2026 (%)
o Exhibit 40: Data Table on ASD - Year-over-year growth 2021-2026 (%)
o 5.6 MS - Market size and forecast 2021-2026
o Exhibit 41: Chart on MS - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Data Table on MS - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Chart on MS - Year-over-year growth 2021-2026 (%)
o Exhibit 44: Data Table on MS - Year-over-year growth 2021-2026 (%)
o 5.7 Others - Market size and forecast 2021-2026
o Exhibit 45: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 46: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 48: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.8 Market opportunity by Indication
o Exhibit 49: Market opportunity by Indication ($ million)
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 50: Chart on End-user - Market share 2021-2026 (%)
o Exhibit 51: Data Table on End-user - Market share 2021-2026 (%)
o 6.2 Comparison by End-user
o Exhibit 52: Chart on Comparison by End-user
o Exhibit 53: Data Table on Comparison by End-user
o 6.3 Hospitals - Market size and forecast 2021-2026
o Exhibit 54: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
o 6.4 Clinical diagnostic centers - Market size and forecast 2021-2026
o Exhibit 58: Chart on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)
o 6.5 Research organizations and others - Market size and forecast 2021-2026
o Exhibit 62: Chart on Research organizations and others - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Research organizations and others - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Research organizations and others - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Research organizations and others - Year-over-year growth 2021-2026 (%)
o 6.6 Market opportunity by End-user
o Exhibit 66: Market opportunity by End-user ($ million)
• 7 Customer Landscape
o 7.1 Customer landscape overview
o Exhibit 67: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 8 Geographic Landscape
o 8.1 Geographic segmentation
o Exhibit 68: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 69: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 8.2 Geographic comparison
o Exhibit 70: Chart on Geographic comparison
o Exhibit 71: Data Table on Geographic comparison
o 8.3 North America - Market size and forecast 2021-2026
o Exhibit 72: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 73: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 74: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 75: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 8.4 Europe - Market size and forecast 2021-2026
o Exhibit 76: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 77: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 78: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 79: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 8.5 Asia - Market size and forecast 2021-2026
o Exhibit 80: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 81: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 82: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 83: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 8.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 84: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 85: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 86: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 87: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 8.7 US - Market size and forecast 2021-2026
o Exhibit 88: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 89: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 90: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 91: Data Table on US - Year-over-year growth 2021-2026 (%)
o 8.8 Germany - Market size and forecast 2021-2026
o Exhibit 92: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 93: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 94: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 95: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 8.9 UK - Market size and forecast 2021-2026
o Exhibit 96: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 97: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 98: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 99: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 8.10 Canada - Market size and forecast 2021-2026
o Exhibit 100: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 101: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 102: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 103: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 8.11 France - Market size and forecast 2021-2026
o Exhibit 104: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 105: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 106: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 107: Data Table on France - Year-over-year growth 2021-2026 (%)
o 8.12 Market opportunity By Geographical Landscape
o Exhibit 108: Market opportunity By Geographical Landscape ($ million)
• 9 Drivers, Challenges, and Trends
o 9.1 Market drivers
o 9.2 Market challenges
o 9.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2021 and 2026
o 9.4 Market trends
• 10 Vendor Landscape
o 10.1 Overview
o 10.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 10.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 10.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 11 Vendor Analysis
o 11.1 Vendors covered
o Exhibit 113: Vendors covered
o 11.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 11.3 Bio Rad Laboratories Inc.
o Exhibit 115: Bio Rad Laboratories Inc. - Overview
o Exhibit 116: Bio Rad Laboratories Inc. - Business segments
o Exhibit 117: Bio Rad Laboratories Inc. - Key news
o Exhibit 118: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 119: Bio Rad Laboratories Inc. - Segment focus
o 11.4 bioMerieux SA
o Exhibit 120: bioMerieux SA - Overview
o Exhibit 121: bioMerieux SA - Business segments
o Exhibit 122: bioMerieux SA - Key offerings
o Exhibit 123: bioMerieux SA - Segment focus
o 11.5 Charles River Laboratories International Inc.
o Exhibit 124: Charles River Laboratories International Inc. - Overview
o Exhibit 125: Charles River Laboratories International Inc. - Business segments
o Exhibit 126: Charles River Laboratories International Inc. - Key news
o Exhibit 127: Charles River Laboratories International Inc. - Key offerings
o Exhibit 128: Charles River Laboratories International Inc. - Segment focus
o 11.6 F. Hoffmann La Roche Ltd.
o Exhibit 129: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 130: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 131: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 132: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 133: F. Hoffmann La Roche Ltd. - Segment focus
o 11.7 Merck KGaA
o Exhibit 134: Merck KGaA - Overview
o Exhibit 135: Merck KGaA - Business segments
o Exhibit 136: Merck KGaA - Key news
o Exhibit 137: Merck KGaA - Key offerings
o Exhibit 138: Merck KGaA - Segment focus
o 11.8 Myriad Genetics Inc.
o Exhibit 139: Myriad Genetics Inc. - Overview
o Exhibit 140: Myriad Genetics Inc. - Product / Service
o Exhibit 141: Myriad Genetics Inc. - Key offerings
o 11.9 Proteome Sciences plc
o Exhibit 142: Proteome Sciences plc - Overview
o Exhibit 143: Proteome Sciences plc - Product / Service
o Exhibit 144: Proteome Sciences plc - Key offerings
o 11.10 QIAGEN NV
o Exhibit 145: QIAGEN NV - Overview
o Exhibit 146: QIAGEN NV - Product / Service
o Exhibit 147: QIAGEN NV - Key news
o Exhibit 148: QIAGEN NV - Key offerings
o 11.11 Quanterix Corp.
o Exhibit 149: Quanterix Corp. - Overview
o Exhibit 150: Quanterix Corp. - Product / Service
o Exhibit 151: Quanterix Corp. - Key offerings
o 11.12 Thermo Fisher Scientific Inc.
o Exhibit 152: Thermo Fisher Scientific Inc. - Overview
o Exhibit 153: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 154: Thermo Fisher Scientific Inc. - Key news
o Exhibit 155: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 156: Thermo Fisher Scientific Inc. - Segment focus
• 12 Appendix
o 12.1 Scope of the report
o 12.2 Inclusions and exclusions checklist
o Exhibit 157: Inclusions checklist
o Exhibit 158: Exclusions checklist
o 12.3 Currency conversion rates for US$
o Exhibit 159: Currency conversion rates for US$
o 12.4 Research methodology
o Exhibit 160: Research methodology
o Exhibit 161: Validation techniques employed for market sizing
o Exhibit 162: Information sources
o 12.5 List of abbreviations
o Exhibit 163: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits18: Five forces analysis - Comparison between 2021 and 2026
Exhibits19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits21: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits22: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits23: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits24: Chart on Market condition - Five forces 2021 and 2026
Exhibits25: Chart on Indication - Market share 2021-2026 (%)
Exhibits26: Data Table on Indication - Market share 2021-2026 (%)
Exhibits27: Chart on Comparison by Indication
Exhibits28: Data Table on Comparison by Indication
Exhibits29: Chart on AD - Market size and forecast 2021-2026 ($ million)
Exhibits30: Data Table on AD - Market size and forecast 2021-2026 ($ million)
Exhibits31: Chart on AD - Year-over-year growth 2021-2026 (%)
Exhibits32: Data Table on AD - Year-over-year growth 2021-2026 (%)
Exhibits33: Chart on PD - Market size and forecast 2021-2026 ($ million)
Exhibits34: Data Table on PD - Market size and forecast 2021-2026 ($ million)
Exhibits35: Chart on PD - Year-over-year growth 2021-2026 (%)
Exhibits36: Data Table on PD - Year-over-year growth 2021-2026 (%)
Exhibits37: Chart on ASD - Market size and forecast 2021-2026 ($ million)
Exhibits38: Data Table on ASD - Market size and forecast 2021-2026 ($ million)
Exhibits39: Chart on ASD - Year-over-year growth 2021-2026 (%)
Exhibits40: Data Table on ASD - Year-over-year growth 2021-2026 (%)
Exhibits41: Chart on MS - Market size and forecast 2021-2026 ($ million)
Exhibits42: Data Table on MS - Market size and forecast 2021-2026 ($ million)
Exhibits43: Chart on MS - Year-over-year growth 2021-2026 (%)
Exhibits44: Data Table on MS - Year-over-year growth 2021-2026 (%)
Exhibits45: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits46: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits47: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits48: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits49: Market opportunity by Indication ($ million)
Exhibits50: Chart on End-user - Market share 2021-2026 (%)
Exhibits51: Data Table on End-user - Market share 2021-2026 (%)
Exhibits52: Chart on Comparison by End-user
Exhibits53: Data Table on Comparison by End-user
Exhibits54: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Research organizations and others - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Research organizations and others - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Research organizations and others - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Research organizations and others - Year-over-year growth 2021-2026 (%)
Exhibits66: Market opportunity by End-user ($ million)
Exhibits67: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits68: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits69: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits70: Chart on Geographic comparison
Exhibits71: Data Table on Geographic comparison
Exhibits72: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits73: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits74: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits75: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits76: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits77: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits78: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits79: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits80: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits81: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits82: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits83: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits84: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits85: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits86: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits87: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits88: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits89: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits90: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits91: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits92: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits93: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits94: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits95: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits96: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits97: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits98: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits99: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits100: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits101: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits102: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits103: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits104: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits105: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits106: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits107: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits108: Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2021 and 2026
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Bio Rad Laboratories Inc. - Overview
Exhibits116: Bio Rad Laboratories Inc. - Business segments
Exhibits117: Bio Rad Laboratories Inc. - Key news
Exhibits118: Bio Rad Laboratories Inc. - Key offerings
Exhibits119: Bio Rad Laboratories Inc. - Segment focus
Exhibits120: bioMerieux SA - Overview
Exhibits121: bioMerieux SA - Business segments
Exhibits122: bioMerieux SA - Key offerings
Exhibits123: bioMerieux SA - Segment focus
Exhibits124: Charles River Laboratories International Inc. - Overview
Exhibits125: Charles River Laboratories International Inc. - Business segments
Exhibits126: Charles River Laboratories International Inc. - Key news
Exhibits127: Charles River Laboratories International Inc. - Key offerings
Exhibits128: Charles River Laboratories International Inc. - Segment focus
Exhibits129: F. Hoffmann La Roche Ltd. - Overview
Exhibits130: F. Hoffmann La Roche Ltd. - Business segments
Exhibits131: F. Hoffmann La Roche Ltd. - Key news
Exhibits132: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits133: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits134: Merck KGaA - Overview
Exhibits135: Merck KGaA - Business segments
Exhibits136: Merck KGaA - Key news
Exhibits137: Merck KGaA - Key offerings
Exhibits138: Merck KGaA - Segment focus
Exhibits139: Myriad Genetics Inc. - Overview
Exhibits140: Myriad Genetics Inc. - Product / Service
Exhibits141: Myriad Genetics Inc. - Key offerings
Exhibits142: Proteome Sciences plc - Overview
Exhibits143: Proteome Sciences plc - Product / Service
Exhibits144: Proteome Sciences plc - Key offerings
Exhibits145: QIAGEN NV - Overview
Exhibits146: QIAGEN NV - Product / Service
Exhibits147: QIAGEN NV - Key news
Exhibits148: QIAGEN NV - Key offerings
Exhibits149: Quanterix Corp. - Overview
Exhibits150: Quanterix Corp. - Product / Service
Exhibits151: Quanterix Corp. - Key offerings
Exhibits152: Thermo Fisher Scientific Inc. - Overview
Exhibits153: Thermo Fisher Scientific Inc. - Business segments
Exhibits154: Thermo Fisher Scientific Inc. - Key news
Exhibits155: Thermo Fisher Scientific Inc. - Key offerings
Exhibits156: Thermo Fisher Scientific Inc. - Segment focus
Exhibits157: Inclusions checklist
Exhibits158: Exclusions checklist
Exhibits159: Currency conversion rates for US$
Exhibits160: Research methodology
Exhibits161: Validation techniques employed for market sizing
Exhibits162: Information sources
Exhibits163: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Neurological Biomarkers Market 2022-2026
Technavio has been monitoring the neurological biomarkers market and it is poised to grow by $ 6.00 bn during 2022-2026, accelerating at a CAGR of 12.43% during the forecast period. Our report on the neurological biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidences of neurological disorders, increasing clinical trials in countries, and increasing initiatives and support from governments and healthcare organizations.
The neurological biomarkers market analysis includes the end-user segment and geographic landscape.
Technavio's neurological biomarkers market is segmented as below:
By End-user
• Hospitals
• Clinical diagnostic centers
• Research organizations and others
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the increasing focus on accurate neurological diagnostics as one of the prime reasons driving the neurological biomarkers market growth during the next few years. Also, blood-based biomarkers for neurological disorders and the evolution of miRNA will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on neurological biomarkers market covers the following areas:
• Neurological biomarkers market sizing
• Neurological biomarkers market forecast
• Neurological biomarkers market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurological biomarkers market vendors that include Bio Rad Laboratories Inc., Proteome Sciences plc, QIAGEN NV, Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann La Roche Ltd., Myriad Genetics Inc., bioMerieux SA, Charles River Laboratories International Inc., Quest Diagnostics Inc., PerkinElmer Inc., Metabolon Inc., Acrobiosystems Inc., HU Group Holdings Inc., Enzo Biochem Inc., Eli Lilly and Co., Abbott Laboratories, Advanced Brain Monitoring Inc., Johnson and Johnson, and Quanterix Corp.. Also, the neurological biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/neurological-biomarkers-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 18: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 21: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 22: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 23: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 24: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Indication
o 5.1 Market segments
o Exhibit 25: Chart on Indication - Market share 2021-2026 (%)
o Exhibit 26: Data Table on Indication - Market share 2021-2026 (%)
o 5.2 Comparison by Indication
o Exhibit 27: Chart on Comparison by Indication
o Exhibit 28: Data Table on Comparison by Indication
o 5.3 AD - Market size and forecast 2021-2026
o Exhibit 29: Chart on AD - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Data Table on AD - Market size and forecast 2021-2026 ($ million)
o Exhibit 31: Chart on AD - Year-over-year growth 2021-2026 (%)
o Exhibit 32: Data Table on AD - Year-over-year growth 2021-2026 (%)
o 5.4 PD - Market size and forecast 2021-2026
o Exhibit 33: Chart on PD - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Data Table on PD - Market size and forecast 2021-2026 ($ million)
o Exhibit 35: Chart on PD - Year-over-year growth 2021-2026 (%)
o Exhibit 36: Data Table on PD - Year-over-year growth 2021-2026 (%)
o 5.5 ASD - Market size and forecast 2021-2026
o Exhibit 37: Chart on ASD - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Data Table on ASD - Market size and forecast 2021-2026 ($ million)
o Exhibit 39: Chart on ASD - Year-over-year growth 2021-2026 (%)
o Exhibit 40: Data Table on ASD - Year-over-year growth 2021-2026 (%)
o 5.6 MS - Market size and forecast 2021-2026
o Exhibit 41: Chart on MS - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Data Table on MS - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Chart on MS - Year-over-year growth 2021-2026 (%)
o Exhibit 44: Data Table on MS - Year-over-year growth 2021-2026 (%)
o 5.7 Others - Market size and forecast 2021-2026
o Exhibit 45: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 46: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 48: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.8 Market opportunity by Indication
o Exhibit 49: Market opportunity by Indication ($ million)
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 50: Chart on End-user - Market share 2021-2026 (%)
o Exhibit 51: Data Table on End-user - Market share 2021-2026 (%)
o 6.2 Comparison by End-user
o Exhibit 52: Chart on Comparison by End-user
o Exhibit 53: Data Table on Comparison by End-user
o 6.3 Hospitals - Market size and forecast 2021-2026
o Exhibit 54: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
o 6.4 Clinical diagnostic centers - Market size and forecast 2021-2026
o Exhibit 58: Chart on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)
o 6.5 Research organizations and others - Market size and forecast 2021-2026
o Exhibit 62: Chart on Research organizations and others - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Research organizations and others - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Research organizations and others - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Research organizations and others - Year-over-year growth 2021-2026 (%)
o 6.6 Market opportunity by End-user
o Exhibit 66: Market opportunity by End-user ($ million)
• 7 Customer Landscape
o 7.1 Customer landscape overview
o Exhibit 67: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 8 Geographic Landscape
o 8.1 Geographic segmentation
o Exhibit 68: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 69: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 8.2 Geographic comparison
o Exhibit 70: Chart on Geographic comparison
o Exhibit 71: Data Table on Geographic comparison
o 8.3 North America - Market size and forecast 2021-2026
o Exhibit 72: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 73: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 74: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 75: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 8.4 Europe - Market size and forecast 2021-2026
o Exhibit 76: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 77: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 78: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 79: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 8.5 Asia - Market size and forecast 2021-2026
o Exhibit 80: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 81: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 82: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 83: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 8.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 84: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 85: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 86: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 87: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 8.7 US - Market size and forecast 2021-2026
o Exhibit 88: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 89: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 90: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 91: Data Table on US - Year-over-year growth 2021-2026 (%)
o 8.8 Germany - Market size and forecast 2021-2026
o Exhibit 92: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 93: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 94: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 95: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 8.9 UK - Market size and forecast 2021-2026
o Exhibit 96: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 97: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 98: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 99: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 8.10 Canada - Market size and forecast 2021-2026
o Exhibit 100: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 101: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 102: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 103: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 8.11 France - Market size and forecast 2021-2026
o Exhibit 104: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 105: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 106: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 107: Data Table on France - Year-over-year growth 2021-2026 (%)
o 8.12 Market opportunity By Geographical Landscape
o Exhibit 108: Market opportunity By Geographical Landscape ($ million)
• 9 Drivers, Challenges, and Trends
o 9.1 Market drivers
o 9.2 Market challenges
o 9.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2021 and 2026
o 9.4 Market trends
• 10 Vendor Landscape
o 10.1 Overview
o 10.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 10.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 10.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 11 Vendor Analysis
o 11.1 Vendors covered
o Exhibit 113: Vendors covered
o 11.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 11.3 Bio Rad Laboratories Inc.
o Exhibit 115: Bio Rad Laboratories Inc. - Overview
o Exhibit 116: Bio Rad Laboratories Inc. - Business segments
o Exhibit 117: Bio Rad Laboratories Inc. - Key news
o Exhibit 118: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 119: Bio Rad Laboratories Inc. - Segment focus
o 11.4 bioMerieux SA
o Exhibit 120: bioMerieux SA - Overview
o Exhibit 121: bioMerieux SA - Business segments
o Exhibit 122: bioMerieux SA - Key offerings
o Exhibit 123: bioMerieux SA - Segment focus
o 11.5 Charles River Laboratories International Inc.
o Exhibit 124: Charles River Laboratories International Inc. - Overview
o Exhibit 125: Charles River Laboratories International Inc. - Business segments
o Exhibit 126: Charles River Laboratories International Inc. - Key news
o Exhibit 127: Charles River Laboratories International Inc. - Key offerings
o Exhibit 128: Charles River Laboratories International Inc. - Segment focus
o 11.6 F. Hoffmann La Roche Ltd.
o Exhibit 129: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 130: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 131: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 132: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 133: F. Hoffmann La Roche Ltd. - Segment focus
o 11.7 Merck KGaA
o Exhibit 134: Merck KGaA - Overview
o Exhibit 135: Merck KGaA - Business segments
o Exhibit 136: Merck KGaA - Key news
o Exhibit 137: Merck KGaA - Key offerings
o Exhibit 138: Merck KGaA - Segment focus
o 11.8 Myriad Genetics Inc.
o Exhibit 139: Myriad Genetics Inc. - Overview
o Exhibit 140: Myriad Genetics Inc. - Product / Service
o Exhibit 141: Myriad Genetics Inc. - Key offerings
o 11.9 Proteome Sciences plc
o Exhibit 142: Proteome Sciences plc - Overview
o Exhibit 143: Proteome Sciences plc - Product / Service
o Exhibit 144: Proteome Sciences plc - Key offerings
o 11.10 QIAGEN NV
o Exhibit 145: QIAGEN NV - Overview
o Exhibit 146: QIAGEN NV - Product / Service
o Exhibit 147: QIAGEN NV - Key news
o Exhibit 148: QIAGEN NV - Key offerings
o 11.11 Quanterix Corp.
o Exhibit 149: Quanterix Corp. - Overview
o Exhibit 150: Quanterix Corp. - Product / Service
o Exhibit 151: Quanterix Corp. - Key offerings
o 11.12 Thermo Fisher Scientific Inc.
o Exhibit 152: Thermo Fisher Scientific Inc. - Overview
o Exhibit 153: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 154: Thermo Fisher Scientific Inc. - Key news
o Exhibit 155: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 156: Thermo Fisher Scientific Inc. - Segment focus
• 12 Appendix
o 12.1 Scope of the report
o 12.2 Inclusions and exclusions checklist
o Exhibit 157: Inclusions checklist
o Exhibit 158: Exclusions checklist
o 12.3 Currency conversion rates for US$
o Exhibit 159: Currency conversion rates for US$
o 12.4 Research methodology
o Exhibit 160: Research methodology
o Exhibit 161: Validation techniques employed for market sizing
o Exhibit 162: Information sources
o 12.5 List of abbreviations
o Exhibit 163: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits18: Five forces analysis - Comparison between 2021 and 2026
Exhibits19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits21: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits22: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits23: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits24: Chart on Market condition - Five forces 2021 and 2026
Exhibits25: Chart on Indication - Market share 2021-2026 (%)
Exhibits26: Data Table on Indication - Market share 2021-2026 (%)
Exhibits27: Chart on Comparison by Indication
Exhibits28: Data Table on Comparison by Indication
Exhibits29: Chart on AD - Market size and forecast 2021-2026 ($ million)
Exhibits30: Data Table on AD - Market size and forecast 2021-2026 ($ million)
Exhibits31: Chart on AD - Year-over-year growth 2021-2026 (%)
Exhibits32: Data Table on AD - Year-over-year growth 2021-2026 (%)
Exhibits33: Chart on PD - Market size and forecast 2021-2026 ($ million)
Exhibits34: Data Table on PD - Market size and forecast 2021-2026 ($ million)
Exhibits35: Chart on PD - Year-over-year growth 2021-2026 (%)
Exhibits36: Data Table on PD - Year-over-year growth 2021-2026 (%)
Exhibits37: Chart on ASD - Market size and forecast 2021-2026 ($ million)
Exhibits38: Data Table on ASD - Market size and forecast 2021-2026 ($ million)
Exhibits39: Chart on ASD - Year-over-year growth 2021-2026 (%)
Exhibits40: Data Table on ASD - Year-over-year growth 2021-2026 (%)
Exhibits41: Chart on MS - Market size and forecast 2021-2026 ($ million)
Exhibits42: Data Table on MS - Market size and forecast 2021-2026 ($ million)
Exhibits43: Chart on MS - Year-over-year growth 2021-2026 (%)
Exhibits44: Data Table on MS - Year-over-year growth 2021-2026 (%)
Exhibits45: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits46: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits47: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits48: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits49: Market opportunity by Indication ($ million)
Exhibits50: Chart on End-user - Market share 2021-2026 (%)
Exhibits51: Data Table on End-user - Market share 2021-2026 (%)
Exhibits52: Chart on Comparison by End-user
Exhibits53: Data Table on Comparison by End-user
Exhibits54: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Research organizations and others - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Research organizations and others - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Research organizations and others - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Research organizations and others - Year-over-year growth 2021-2026 (%)
Exhibits66: Market opportunity by End-user ($ million)
Exhibits67: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits68: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits69: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits70: Chart on Geographic comparison
Exhibits71: Data Table on Geographic comparison
Exhibits72: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits73: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits74: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits75: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits76: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits77: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits78: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits79: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits80: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits81: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits82: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits83: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits84: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits85: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits86: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits87: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits88: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits89: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits90: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits91: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits92: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits93: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits94: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits95: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits96: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits97: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits98: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits99: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits100: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits101: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits102: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits103: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits104: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits105: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits106: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits107: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits108: Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2021 and 2026
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Bio Rad Laboratories Inc. - Overview
Exhibits116: Bio Rad Laboratories Inc. - Business segments
Exhibits117: Bio Rad Laboratories Inc. - Key news
Exhibits118: Bio Rad Laboratories Inc. - Key offerings
Exhibits119: Bio Rad Laboratories Inc. - Segment focus
Exhibits120: bioMerieux SA - Overview
Exhibits121: bioMerieux SA - Business segments
Exhibits122: bioMerieux SA - Key offerings
Exhibits123: bioMerieux SA - Segment focus
Exhibits124: Charles River Laboratories International Inc. - Overview
Exhibits125: Charles River Laboratories International Inc. - Business segments
Exhibits126: Charles River Laboratories International Inc. - Key news
Exhibits127: Charles River Laboratories International Inc. - Key offerings
Exhibits128: Charles River Laboratories International Inc. - Segment focus
Exhibits129: F. Hoffmann La Roche Ltd. - Overview
Exhibits130: F. Hoffmann La Roche Ltd. - Business segments
Exhibits131: F. Hoffmann La Roche Ltd. - Key news
Exhibits132: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits133: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits134: Merck KGaA - Overview
Exhibits135: Merck KGaA - Business segments
Exhibits136: Merck KGaA - Key news
Exhibits137: Merck KGaA - Key offerings
Exhibits138: Merck KGaA - Segment focus
Exhibits139: Myriad Genetics Inc. - Overview
Exhibits140: Myriad Genetics Inc. - Product / Service
Exhibits141: Myriad Genetics Inc. - Key offerings
Exhibits142: Proteome Sciences plc - Overview
Exhibits143: Proteome Sciences plc - Product / Service
Exhibits144: Proteome Sciences plc - Key offerings
Exhibits145: QIAGEN NV - Overview
Exhibits146: QIAGEN NV - Product / Service
Exhibits147: QIAGEN NV - Key news
Exhibits148: QIAGEN NV - Key offerings
Exhibits149: Quanterix Corp. - Overview
Exhibits150: Quanterix Corp. - Product / Service
Exhibits151: Quanterix Corp. - Key offerings
Exhibits152: Thermo Fisher Scientific Inc. - Overview
Exhibits153: Thermo Fisher Scientific Inc. - Business segments
Exhibits154: Thermo Fisher Scientific Inc. - Key news
Exhibits155: Thermo Fisher Scientific Inc. - Key offerings
Exhibits156: Thermo Fisher Scientific Inc. - Segment focus
Exhibits157: Inclusions checklist
Exhibits158: Exclusions checklist
Exhibits159: Currency conversion rates for US$
Exhibits160: Research methodology
Exhibits161: Validation techniques employed for market sizing
Exhibits162: Information sources
Exhibits163: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(biomarkers market)の最新刊レポート


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/09/20 10:26

143.76 円

160.81 円

193.57 円

ページTOPに戻る